TY - JOUR
T1 - Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution
AU - Arai, Kazuaki
AU - Hirakata, Yoichi
AU - Yano, Hisakazu
AU - Kanamori, Hajime
AU - Endo, Shiro
AU - Hirotani, Ayako
AU - Abe, Yuko
AU - Nagasawa, Mitsuaki
AU - Kitagawa, Miho
AU - Aoyagi, Tetsuji
AU - Hatta, Masumitsu
AU - Yamada, Mitsuhiro
AU - Nishimaki, Katsushi
AU - Takayama, Yoko
AU - Yamamoto, Natsuo
AU - Kunishima, Hiroyuki
AU - Kaku, Mitsuo
N1 - Funding Information:
This work was supported by Tohoku University and the Ministry of Education, Culture, Sports, Science and Technology, Japan.
PY - 2011/3
Y1 - 2011/3
N2 - Objectives: Streptococcus pyogenes causes various diseases in humans. While the prevalence of fluoroquinolone-resistant S. pyogenes isolates has been increasing since 2000 in the USA and Europe, it has remained very low in Japan. We isolated a fluoroquinolone-resistant S. pyogenes strain and analysed its genetics. Methods: TU-296, a strain of S. pyogenes resistant to levofloxacin (MIC 16 mg/L), was isolated from the throat of a patient in their thirties with pharyngitis in autumn 2007. We carried out susceptibility tests for various antimicrobial agents and PCR analysis of the genes gyrA, gyrB, parC and parE in the quinolone resistance-determining region, followed by sequencing of the PCR products to find mutation(s) and the resulting amino acid substitution(s). We then sequenced the PCR product of the emm gene and determined the emm genotype. Results: S. pyogenes TU-296 was found to have the following mutations and amino acid substitutions: adenine 476 to cytosine in gyrA and cytosine 367 to thymine in parC, resulting in Glu-85→Ala in GyrA and Ser-79→Phe in ParC. The genotype of the isolate was emm11. Conclusions: Amino acid substitutions in fluoroquinolone-resistant S. pyogenes have already been reported from Europe and the USA, including Ser-81→Phe or Tyr and Met-99→Leu in GyrA, as well as Ser-79→Phe, Tyr or Ala and others in ParC. Numerous point mutations were found in parC and parE of S. pyogenes TU-296. In addition, a new amino acid substitution was detected (Glu-85→Ala in GyrA). To our knowledge, there have been no previous reports of this substitution in a clinical isolate of S. pyogenes.
AB - Objectives: Streptococcus pyogenes causes various diseases in humans. While the prevalence of fluoroquinolone-resistant S. pyogenes isolates has been increasing since 2000 in the USA and Europe, it has remained very low in Japan. We isolated a fluoroquinolone-resistant S. pyogenes strain and analysed its genetics. Methods: TU-296, a strain of S. pyogenes resistant to levofloxacin (MIC 16 mg/L), was isolated from the throat of a patient in their thirties with pharyngitis in autumn 2007. We carried out susceptibility tests for various antimicrobial agents and PCR analysis of the genes gyrA, gyrB, parC and parE in the quinolone resistance-determining region, followed by sequencing of the PCR products to find mutation(s) and the resulting amino acid substitution(s). We then sequenced the PCR product of the emm gene and determined the emm genotype. Results: S. pyogenes TU-296 was found to have the following mutations and amino acid substitutions: adenine 476 to cytosine in gyrA and cytosine 367 to thymine in parC, resulting in Glu-85→Ala in GyrA and Ser-79→Phe in ParC. The genotype of the isolate was emm11. Conclusions: Amino acid substitutions in fluoroquinolone-resistant S. pyogenes have already been reported from Europe and the USA, including Ser-81→Phe or Tyr and Met-99→Leu in GyrA, as well as Ser-79→Phe, Tyr or Ala and others in ParC. Numerous point mutations were found in parC and parE of S. pyogenes TU-296. In addition, a new amino acid substitution was detected (Glu-85→Ala in GyrA). To our knowledge, there have been no previous reports of this substitution in a clinical isolate of S. pyogenes.
KW - Group A Streptococcus
KW - GyrA
KW - ParC
KW - S. dysgalactiae subsp. equisimilis
KW - Substitution of amino acid
UR - http://www.scopus.com/inward/record.url?scp=79951547913&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951547913&partnerID=8YFLogxK
U2 - 10.1093/jac/dkq477
DO - 10.1093/jac/dkq477
M3 - Article
C2 - 21172783
AN - SCOPUS:79951547913
VL - 66
SP - 494
EP - 498
JO - Journal of Antimicrobial Chemotherapy
JF - Journal of Antimicrobial Chemotherapy
SN - 0305-7453
IS - 3
M1 - dkq477
ER -